Back To Schedule
Tuesday, March 10 • 10:00am - 10:45am
Compare and Contrast Different Operating Models for Search and Evaluation to Advance Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Analyze new growth opportunities and how they should align favorably with your company’s growth culture and objectives
  • Discuss the various formal processes, metrics, and models for prioritization
  • Understand the broader goals of your business development strategy, such as geographic expansion, market share increases, and accelerated top-line growth
  • Weigh the pros and cons of R&D and innovation hubs as a way to partner with existing ecosystems

avatar for Angele Maki, Ph.D.

Angele Maki, Ph.D.

Vice President, Emerging Technology and Innovation, ELI LILLY AND COMPANY
avatar for Jennifer Leeds, Ph.D.

Jennifer Leeds, Ph.D.

Executive Director, BD&L, NOVARTIS
avatar for Ravi Kiron, Ph.D., MBA

Ravi Kiron, Ph.D., MBA

Head, BioPharma External Innovation, EMD SERONO/MERCK KGAA, DARMSTADT, GERMANY
Dr. Ravi Kiron based in California, USA is an experienced pharma/biotech executive with decades of experience in discovery R&D through late-stage clinical development, intellectual property and regulatory, technology & business development, M&A, strategy and product commercialization... Read More →
avatar for Lisa Mendoza, Ph.D.

Lisa Mendoza, Ph.D.

Director External Research and Alliances, BAYER
Dr. Lisa Mendoza is Director with Bayer’s R&D partnering organization located in San Francisco at Bayer’s Open Innovation Center.  Dr. Mendoza has established partnerships with academic and biotech researchers focused on novel therapeutics of strategic interest to Bayer with... Read More →

Tuesday March 10, 2020 10:00am - 10:45am
Presidio Ballroom